DEF: Trust Stamp Seeks Stockholder Approval for Private Placement Warrants Issuance

Trust Stamp is holding a special meeting to ratify the issuance of private placement warrants to Armistice Capital Master Fund Ltd., as required by Nasdaq listing rules.

Summary

• Trust Stamp is seeking stockholder approval to ratify the issuance of private placement warrants to Armistice Capital Master Fund Ltd. related to a Securities Purchase Agreement (Armistice SPA) dated December 5, 2024.
• The warrants consist of Series A warrants for up to 370,370 shares and Series B warrants for up to 277,778 shares of Class A Common Stock, both at an exercise price of $8.10 per share.
• The company previously attempted to obtain shareholder approval on February 7, 2025, but failed to reach a quorum.
• Nasdaq Listing Rule 5635(d) requires stockholder approval for the issuance of securities exceeding 20% of outstanding common stock at a price less than the minimum price.
• Failure to approve the proposal could prevent the exercise of the warrants, costing the company up to $5,249,992.86 in gross proceeds and requiring additional meetings every 90 days to seek approval.
• Approval could lead to dilution of existing stockholders' ownership due to the potential issuance of 648,148 shares of Class A Common Stock upon warrant exercise.

Sentiment

Score: 6

Explanation: The document is primarily procedural, seeking approval for a previously executed financing agreement. While the potential dilution is a negative, the additional capital is a positive. The sentiment is neutral to slightly positive.

Positives

• If the warrants are exercised, Trust Stamp could receive up to $5,249,992.86 in gross proceeds, which would be used for working capital, capital expenditures, and general corporate purposes.

Negatives

• Failure to obtain stockholder approval will mean we cannot permit the exercise of the Private Placement Warrants.
• Failure to obtain stockholder approval may incur substantial additional costs and expenses because we will need to hold another meeting every ninety (90) to vote upon this proposal until it is approved.
• Approval of the warrant issuance could lead to dilution of existing stockholders' ownership.

Risks

• Failure to obtain stockholder approval could prevent the exercise of the warrants, costing the company potential proceeds.
• The market price of Trust Stamp's Class A Common Stock could be materially and adversely affected by the sale of shares issued upon exercise of the warrants.
• Existing stockholders will suffer dilution in their ownership interests if the warrants are exercised.

Future Outlook

The company intends to use the net proceeds from the Armistice SPA for working capital, capital expenditures, and other general corporate purposes.

Management Comments

• We encourage you to review the proxy materials and vote as soon as possible.
• Your vote is important.

Industry Context

This type of financing and the need for shareholder approval are common in the micro-cap and small-cap sectors, particularly when companies need to raise capital quickly.

Comparison to Industry Standards

• The terms of the warrants, including the exercise price and cashless exercise provisions, are fairly standard for private placements in the current market.
• Companies like Digital Ally and Document Security Systems have used similar financing structures involving warrants and private placements.
• The 7% placement agent fee is within the typical range for such transactions.

Stakeholder Impact

• Approval of the proposal could dilute existing shareholders' ownership.
• If the warrants are exercised, the company will have additional capital to fund its operations, which could benefit employees and customers.
• Failure to approve the proposal could limit the company's access to capital and potentially impact its ability to grow.

Next Steps

• Stockholders need to vote on the proposal to ratify the issuance of the private placement warrants.
• The company will hold the Special Meeting on May 15, 2025, to count the votes and determine the outcome of the proposal.
• The company will file a Current Report on Form 8-K with the SEC to announce the final voting results within four business days following the Special Meeting.

Key Dates

Keywords

Private Placement Warrants, Stockholder Approval, Armistice Capital, Class A Common Stock, Nasdaq Listing Rule, Special Meeting, Dilution, Warrants, Trust Stamp, SPA